The Global Oligosaccharides in Infant Nutrition Market was valued at USD 2.16 Billion in 2024 and is projected to reach USD 3.83 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period (2025–2032). This robust growth is driven by increasing parental awareness of infant gut health benefits, rising demand for premium and specialized infant formulas, and the rapid adoption of advanced ingredients like Human Milk Oligosaccharides (HMOs) that closely mimic the functional benefits of breast milk.

As the global focus on early-life nutrition intensifies, the companies formulating and supplying these critical ingredients are at the forefront of innovation. In this blog, we profile the Top 10 Companies in the Oligosaccharides for Infant Nutrition Industry—a dynamic mix of nutrition science leaders, ingredient innovators, and biotech pioneers shaping the future of infant health worldwide.

---

🔟 1. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: Similac® infant formulas with 2’-FL HMO, GOS (Galacto-oligosaccharides)

Abbott is a global powerhouse in pediatric nutrition, leading the commercialization of HMO-fortified infant formulas. Its flagship brand, Similac, was among the first major brands to incorporate the prebiotic 2’-fucosyllactose (2’-FL), a key HMO found in breast milk, into its product line. This science-backed approach targets the development of a healthy infant gut microbiome and immune system.

Innovation & Market Strategy:

• Pioneered the integration of clinically-studied HMOs into mass-market infant formula.
• Maintains a robust portfolio of specialty formulas for sensitive infants containing targeted oligosaccharide blends.
• Heavy investment in clinical research to validate health outcomes related to HMO supplementation.

Download FREE Sample Report:
Global Oligosaccharides in Infant Nutrition Market – View in Detailed Research Report

---

9️⃣ 2. DuPont Nutrition & Biosciences (International Flavors & Fragrances Inc.)

Headquarters: Wilmington, Delaware, USA
Key Offering: GOS (Galacto-oligosaccharides), FOS (Fructo-oligosaccharides), customized prebiotic blends

DuPont Nutrition & Biosciences, now part of IFF, is a leading global supplier of specialty food ingredients, including a comprehensive range of prebiotic oligosaccharides. Its HOWARU® and Danisco® lines are trusted by infant formula manufacturers worldwide to improve digestive health and stool consistency in formula-fed infants.

Innovation & Market Strategy:

• World-leading production capacity for high-purity GOS, a widely used prebiotic that promotes bifidobacteria.
• Strong focus on B2B partnerships, providing tailored oligosaccharide solutions to major formula brands.
• Continuous R&D in synbiotic combinations (prebiotics + probiotics) for enhanced functionality.

---

8️⃣ 3. FrieslandCampina Domo

Headquarters: Amersfoort, Netherlands
Key Offering: Vivinal® GOS (Galacto-oligosaccharides)

FrieslandCampina Domo is a key player in the GOS market, deriving its core ingredient from dairy by-products. Its Vivinal® GOS is one of the most researched prebiotic fibers for infant nutrition, known for its ability to stimulate the growth of beneficial gut bacteria and support immune development similar to components in human milk.

Innovation & Market Strategy:

• Vertically integrated production from milk sugars ensures consistent quality and supply.
• Extensive scientific dossier supporting the safety and efficacy of Vivinal® GOS in infant formula applications.
• Strategic focus on the high-growth Asia-Pacific infant nutrition market.

---

7️⃣ 4. Nestlé Health Science

Headquarters: Vevey, Switzerland
Key Offering: Infant formulas (e.g., Nestlé NAN) with HMOs and proprietary oligosaccharide blends

While a formula manufacturer itself, Nestlé is a significant force in oligosaccharide application through its extensive R&D and product innovation. The company has launched several infant formula lines containing HMOs and its proprietary blend of prebiotics, investing heavily in nutritional science to close the gap between breast milk and formula.

Innovation & Market Strategy:

• Internal development and external partnerships for sourcing advanced HMOs like LNnT (Lacto-N-neotetraose).
• Global scale allows for rapid roll-out of new oligosaccharide-fortified formulas across diverse markets.
• Strong emphasis on clinical evidence generation to support product claims and build consumer trust.

Download FREE Sample Report:
Global Oligosaccharides in Infant Nutrition Market – View in Detailed Research Report

---

6️⃣ 5. Jennewein Biotechnologie GmbH

Headquarters: Rheinbreitbach, Germany
Key Offering: Human-Identical Milk Oligosaccharides (HMOs) – 2’-FL, LNnT, 3-FL, 6’-SL, others

Jennewein Biotechnologie is a pure-play biotech pioneer specializing in the microbial fermentation production of complex HMOs. It is a key technology and B2B ingredient supplier, enabling other companies to incorporate specific, human-identical HMOs into their products without relying on chemical synthesis from dairy streams.

Innovation & Market Strategy:

• Core expertise in scalable, precision fermentation to produce a broad portfolio of HMOs.
• Critical supplier to leading infant nutrition companies seeking innovative, science-based ingredients.
• Focus on expanding beyond infant nutrition into adult medical nutrition and dietary supplements.

---

5️⃣ 6. Ingredion Incorporated

Headquarters: Westchester, Illinois, USA
Key Offering: NURISH® native inulin (FOS source), specialty carbohydrate solutions

Ingredion provides a wide range of carbohydrate-based texturizers and functional ingredients, including prebiotic fibers used in infant nutrition. Its expertise in plant-based ingredients offers alternative oligosaccharide sources, catering to the growing demand for clean-label and vegetable-derived nutrition solutions.

Innovation & Market Strategy:

• Leverages its global footprint and application expertise to provide tailored nutritional solutions.
• Focus on developing cost-effective, sustainable, and label-friendly prebiotic ingredients.
• Supports manufacturers in achieving desired nutritional profiles and functional benefits in final products.

---

4️⃣ 7. BASF SE (Nutrition & Health Division)

Headquarters: Ludwigshafen, Germany
Key Offering: Prebio® lactulose (a galacto-fructose prebiotic)

BASF’s nutrition division offers lactulose, a well-established prebiotic with a long history of use in pediatric applications for supporting digestive health. While not a classical GOS or HMO, lactulose serves as a functional oligosaccharide that beneficially modulates the infant gut microbiota.

Innovation & Market Strategy:

• Provides a clinically proven prebiotic alternative within the broader oligosaccharide category.
• Combines its chemical manufacturing prowess with nutritional science to ensure high-purity ingredients.
• Integrates its oligosaccharide offerings within a broader portfolio of vitamins and carotenoids for infant health.

---

3️⃣ 8. Royal DSM (now part of dsm-firmenich)

Headquarters: Heerlen, Netherlands
Key Offering: Nutritional lipids, vitamins, and early-stage development in advanced nutritionals

DSM has been a major supplier of critical nutrients to the infant formula industry for decades. While historically focused on vitamins and lipids, its merger and ongoing innovation strategy position it to play a significant role in the development and supply of next-generation nutritional ingredients, including specialized oligosaccharides and synbiotic systems.

Innovation & Market Strategy:

• Strategic investments and partnerships in advanced fermentation and biotechnology for novel ingredients.
• Aims to provide integrated nutritional solutions that combine oligosaccharides with other essential nutrients.
• Strong commitment to sustainability, influencing sourcing and production of future bio-based ingredients.

---

2️⃣ 9. Inbiose NV

Headquarters: Ghent, Belgium
Key Offering: Human Milk Oligosaccharides (HMOs) produced via proprietary enzymatic technology

Inbiose is another European biotech leader using advanced enzymatic glycosylation to produce a wide array of complex HMOs. Its asset-light, precision technology allows for efficient and scalable production of HMOs that are structurally identical to those found in human milk, serving as a key innovation partner for global food and nutrition companies.

Innovation & Market Strategy:

• Specializes in enzymatic synthesis, offering a potentially cost-effective and flexible route to diverse HMOs.
• Active in forging licensing and joint development agreements with large-scale manufacturers.
• Expanding its HMO portfolio to include rarer structures with targeted functional benefits.

Download FREE Sample Report:
Global Oligosaccharides in Infant Nutrition Market – View in Detailed Research Report

---

1️⃣ 10. Mead Johnson Nutrition (Reckitt)

Headquarters: Chicago, Illinois, USA (Parent: Reckitt, Slough, UK)
Key Offering: Enfamil® infant formulas with MFGM, prebiotics, and HMOs (e.g., Enfamil NeuroPro with MFGM & HMO)

As the maker of Enfamil, one of the world’s leading infant formula brands, Mead Johnson Nutrition (part of Reckitt) is a major integrator and driver of oligosaccharide demand. The company continuously innovates its formulations, incorporating blends of prebiotics (like GOS and polydextrose) and now HMOs to support cognitive and immune development.

Innovation & Market Strategy:

• Major market mover whose formulation choices significantly influence upstream ingredient demand.
• Invests in large-scale clinical trials to differentiate its oligosaccharide-fortified products.
• Competes directly with Abbott and Nestlé, accelerating the overall adoption of advanced oligosaccharides in mainstream products.

Read Full Report:
Global Oligosaccharides in Infant Nutrition Market – View in Detailed Research Report

---

👶 Outlook: The Future of Infant Nutrition Is Personalized and Bio-Mimetic

The oligosaccharides in infant nutrition market is undergoing a profound transformation. While established prebiotics like GOS and FOS remain vital, the industry is racing towards more sophisticated, human-milk-inspired solutions that promise to optimize early-life health outcomes.

📈 Key Trends Shaping the Market:

• HMO Dominance: Rapid commercialization and scaling of 2’-FL and LNnT, with a pipeline of other complex HMOs to follow, making formulas more biomimetic than ever.
• Precision & Personalization: Emerging research into tailoring oligosaccharide blends based on infant genotype, microbiome status, or specific health needs (e.g., allergy prevention).
• Geographic Expansion: Surging demand in Asia-Pacific and Latin America, where urbanization, rising incomes, and smaller family sizes are driving premiumization of infant nutrition.
• Sustainable and Diverse Production: Growth of fermentation and enzymatic production methods for HMOs, reducing reliance on animal-derived sources and improving scalability and cost profiles.

Read Full Report:
Global Oligosaccharides in Infant Nutrition Market – View in Detailed Research Report

The companies listed above are not only supplying critical ingredients—they are enabling a scientific revolution in early childhood nutrition, building a foundation for lifelong health one formula at a time.